Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...